This Week
  • New federal employment rules promise to bring a tsunami of change.

  • Distributed Technology Group was acquired by Accunet Solutions, a Boston-based technology company.

  • Meredith Dragon has taken the reins at the Jewish Federation of Greater Rochester.

  • After a merger or acquisition, banks must make all the pieces work together.

  • This year's supplement features an interview with Danny Wegman.

  • Ilana Griffo is a letterer, business owner and lifelong learner.

Reports: Bausch & Lomb close to being acquired

Rochester Business Journal
May 24, 2013

Canada’s largest drugmaker is close to acquiring Bausch & Lomb Inc. in a roughly $9 billion deal, published reports state.

Valeant Pharmaceuticals International Inc. is seeking to acquire the local eye-care company owned by private-equity firm Warburg Pincus LLC, Bloomberg, Reuters and the Wall Street Journal reported Friday afternoon.
 
Warburg reportedly had been shopping Bausch & Lomb to a variety of companies early this year, and then filed for an initial public offering in March after the effort to sell the company for at least $10 billion stalled.

Valeant is seeking acquisitions of companies with solid cash flows in high-growth areas, CEO Mike Pearson said on a conference call with investors earlier this month, Bloomberg reported. The Bausch & Lomb deal would be the largest of 15 acquisitions for Montreal-based Valeant since it was created in a 2010 merger of its U.S. predecessor and Canada’s Biovail Corp.

Private equity firm Warburg Pincus bought Bausch & Lomb for $3.7 billion in September 2007, taking the longtime publicly traded company private.

Bausch & Lomb officials have declined to talk about possible acquisitions of the company.

In an interview with the Rochester Business Journal last July, Bausch & Lomb CEO Brent Saunders said an IPO was more likely than a sale.

The company has posted a loss in each of the last three years, the registration filing states. Its net losses in 2010-2012 attributable to Bausch & Lomb Holdings were $196 million, $123.9 million and $68.3 million, respectively.

Net sales rose from $937.2 million in 2010 to $1.3 billion in 2012.

Bloomberg projected that at $9 billion including debt, Bausch & Lomb would be valued at about 21 times earnings before interest, taxes, depreciation and amortization of $429.5 million in the year through December.
 
5/24/13 (c) 2013 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or email service@rbj.net.


What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment

 
Username:
Password:

Not registered? Sign up now!
 

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google